Get the Stockscreener App
2.70
1.50%
0.04
After Hours:
2.70
Microbot Medical Inc stock is traded at $2.70, with a volume of 962.43K.
It is up +1.50% in the last 24 hours and up +3.45% over the past month.
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.
See More
Previous Close:
$2.66
Open:
$2.7
24h Volume:
962.43K
Relative Volume:
0.42
Market Cap:
$98.23M
Revenue:
-
Net Income/Loss:
$-10.58M
P/E Ratio:
-2.25
EPS:
-1.2
Net Cash Flow:
$-9.21M
1W Performance:
+3.05%
1M Performance:
+3.45%
6M Performance:
+177.78%
1Y Performance:
+164.71%
1-Day Range:
$2.64
$2.7799
1-Week Range:
$2.47
$2.7799
52-Week Range:
$0.82
$3.38
Microbot Medical Inc Stock (MBOT) Company Profile
Name
Microbot Medical Inc
Sector
Industry
Phone
908-938-5561
Address
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Compare MBOT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
2.70 | 99.68M | 0 | -10.58M | -9.21M | -1.20 |
|
ISRG
Intuitive Surgical Inc
|
550.19 | 201.30B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
174.51 | 50.74B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
86.70 | 44.20B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
246.22 | 37.15B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
80.58 | 16.38B | 3.93B | 415.40M | 384.70M | 2.06 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-24-19 | Reiterated | H.C. Wainwright | Buy |
| Jan-31-18 | Initiated | Ladenburg Thalmann | Buy |
Microbot Medical Inc Stock (MBOT) Latest News
Microbot Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Microbot Medical (MBOT) Projected to Post Earnings on Wednesday - Defense World
Renaissance Technologies LLC Takes $118,000 Position in Microbot Medical Inc. (NASDAQ:MBOT) - Defense World
Head to Head Survey: Microbot Medical (NASDAQ:MBOT) versus Hypertension Diagnostics (OTCMKTS:HDII) - Defense World
Geode Capital Management LLC Grows Stock Holdings in Microbot Medical Inc. (NASDAQ:MBOT) - Defense World
Cytosorbents (NASDAQ:CTSO) versus Microbot Medical (NASDAQ:MBOT) Financial Analysis - Defense World
Microbot Medical Releases Updated Presentation Materials - TipRanks
Microbot Medical regains Nasdaq compliance with bid price - MSN
Microbot Medical bolsters leadership ahead of FDA decision By Investing.com - Investing.com South Africa
Microbot Medical® Bolsters Commercial Leadership Team with the A - GuruFocus
Microbot Medical (MBOT) Strengthens U.S. Leadership Ahead of FDA Decision | MBOT Stock News - GuruFocus
Microbot Medical Strengthens Leadership Ahead of LIBERTY Launch - TipRanks
Microbot Medical bolsters leadership ahead of FDA decision - Investing.com
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers | MBOT Stock News - GuruFocus
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers - GlobeNewswire
Microbot Medical Accelerates FDA Launch Plans: Marketing VP with 15-Year Track Record Leads Commercial Push - Stock Titan
Is Microbot Medical Inc. (MBOT) the Best Rising Penny Stock to Buy According to Analysts? - Insider Monkey
10 Best Rising Penny Stocks to Buy According to Analysts - Insider Monkey
Microbot Medical announces proxy statement for annual meeting By Investing.com - Investing.com South Africa
Microbot Medical announces proxy statement for annual meeting - Investing.com
Microbot Medical modifies shareholder meeting quorum By Investing.com - Investing.com Canada
Microbot’s Liberty Boosts Stock: What’s Next? - timothysykes.com
Microbot Medical modifies shareholder meeting quorum - Investing.com
Global Robotic Exoskeleton Market Size Expected to Reach $30 Billion By 2032 as A.I. Influence Disrupts the Industry - GlobeNewswire
HC Wainwright Raises Earnings Estimates for Microbot Medical - Defense World
Microbot Medical's (MBOT) Robotic System Achieves Key Trial Succ - GuruFocus
HC Wainwright Reiterates Buy Rating for Microbot Medical (NASDAQ:MBOT) - Defense World
Microbot Medical clears pivotal study for remote-controlled endovascular procedures - Fierce Biotech
H.C. Wainwright maintains $9 target on Microbot Medical stock By Investing.com - Investing.com South Africa
Microbot Medical (MBOT) Awaits FDA Decision on LIBERTY® Robot - GuruFocus
Microbot posts pivotal surgical robot data; GE Healthcare hires Patient Care Solutions leader - Yahoo Finance
H.C. Wainwright maintains $9 target on Microbot Medical stock - Investing.com
Microbot Medical reports successful robotic trial By Investing.com - Investing.com Canada
Microbot Medical® Shares Results from Its Pivotal Clinical Trial - GuruFocus
Microbot Medical Data Backs Liberty Endovascular Surgical Robot - Medical Product Outsourcing
Sector Update: Health Care Stocks Rise Wednesday Afternoon - TradingView
Sector Update: Health Care - marketscreener.com
Microbot Medical (MBOT) Appoints Paul Mullen as VP of Sales - GuruFocus
Microbot Medical (MBOT) Advances Telesurgery with LIBERTY® Syste - GuruFocus
Microbot Medical (MBOT) Secures $13 Million Through Direct Offering - GuruFocus
Microbot Medical shares results from ACCESS-PVI pivotal trial - Vascular News
Microbot Medical Feels a Strong Surge Again? - timothysykes.com
Microbot Medical (MBOT) Unveils Promising Trial Data for LIBERTY System - GuruFocus
Microbot Medical (MBOT) Surges on Successful Trial Results - GuruFocus
Microbot Medical Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the Liberty® Endovascular Robotic System - MarketScreener
Microbot Medical reports successful robotic trial - Investing.com
Microbot Medical Says Study Shows Endovascular Robotic System Feasible - MarketScreener
Microbot Medical Inc Stock (MBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):